GROS 260MG INJ

GROS 260MG INJ is a medication used to treat various types of cancer, including breast cancer, lung cancer, and ovarian cancer. It is a sterile injection containing Paclitaxel, a microtubule inhibitor that works by interfering with the growth and spread of cancer cells.

Composition:

GROS 260MG INJ is a sterile injection containing Paclitaxel, a microtubule inhibitor.

Indications:

GROS 260MG INJ is indicated for the treatment of:

• Breast cancer (metastatic breast cancer, breast cancer in combination with hormonal therapy)
• Non-small cell lung cancer (NSCLC)
• Ovarian cancer (advanced ovarian cancer)

Mechanism of Action:

Paclitaxel works by:

1. Interfering with the polymerization of microtubules, which are essential for cell division
2. Disrupting the normal functioning of microtubules, leading to apoptosis (cell death)
3. Inhibiting the growth and proliferation of cancer cells

Dosage and Administration:

The recommended dosage of GROS 260MG INJ is:

• 260mg administered as an intravenous infusion over 3-4 hours every 3 weeks
• The dose should be adjusted based on the patient’s response to treatment and tolerability

Side Effects:

Common side effects of GROS 260MG INJ include:

1. Nausea and vomiting
2. Fatigue
3. Anemia
4. Neutropenia
5. Alopecia (hair loss)
6. Arthritis
7. Myalgia (muscle pain)

Serious side effects can include:

1. Neurotoxicity (peripheral neuropathy)
2. Cardiac toxicity (arrhythmias)
3. Hypersensitivity reactions (anaphylaxis)
4. Infusion-related reactions (chest tightness, difficulty breathing)

Contraindications:

GROS 260MG INJ is contraindicated in patients with:

1. Severe hypersensitivity reactions to Paclitaxel or any component of the formulation
2. Severe liver disease
3. Severe kidney disease

Precautions:

1. Patients with a history of cardiac disease should be closely monitored while receiving GROS 260MG INJ.
2. Patients with a history of liver disease should be closely monitored while receiving GROS 260MG INJ.

Patient Counseling:

• Patients should be counseled on the importance of taking their medication as directed and not missing doses.
• Patients should be instructed to report any signs of nausea, vomiting, or diarrhea.
• Patients should be advised to report any changes in their appetite or weight loss.

Storage and Handling:

• Store at room temperature (20°C to 25°C) and protected from light.
• Do not freeze or expose to direct sunlight.
• Use within 24 months of opening.

Please note that the dosage and administration information is based on the recommended dosage and may vary depending on individual patient needs and circumstances.

As with any medication, it is important to consult with a healthcare professional before taking GROS 260MG INJ, especially if you have a history of medical conditions, are taking other medications, or are pregnant or breastfeeding.